{"parse":{"title":"De-linkage","pageid":50462832,"revid":854102655,"text":{"*":"<div class=\"mw-parser-output\"><p><b>De-linkage</b> is a proposed model for development of new <a href=\"/wiki/Pharmaceutical_drug\" class=\"mw-redirect\" title=\"Pharmaceutical drug\">pharmaceutical drugs</a><sup id=\"cite_ref-ch-20150514_1-0\" class=\"reference\"><a href=\"#cite_note-ch-20150514-1\">&#91;1&#93;</a></sup> where \"de-link\" refers to isolating the profitability of a drug from its volume of sales.<sup id=\"cite_ref-amr-201505_2-0\" class=\"reference\"><a href=\"#cite_note-amr-201505-2\">&#91;2&#93;</a></sup>\n</p><p>In the current <a href=\"/wiki/Business_model\" title=\"Business model\">business model</a>, the <a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">pharmaceutical industry</a> relies on the pricing and sales of its products to generate profits and to finance <a href=\"/wiki/Research_and_development\" title=\"Research and development\">research and development</a> of new drugs. This ability is dependent on the <a href=\"/wiki/Monopoly\" title=\"Monopoly\">monopoly</a> granted through <a href=\"/wiki/Patent\" title=\"Patent\">patents</a>.<sup id=\"cite_ref-ch-20150514_1-1\" class=\"reference\"><a href=\"#cite_note-ch-20150514-1\">&#91;1&#93;</a></sup>\n</p><p>In the de-linkage model, other means (such as lump sums) would be used to reward companies for research and development in exchange for restricting the price charged for the product. This would allow the product to be sold at prices closer to production costs which would ensure better access, particularly for poor people and those who pay for their own treatment.<sup id=\"cite_ref-ch-20150514_1-2\" class=\"reference\"><a href=\"#cite_note-ch-20150514-1\">&#91;1&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#De-linkage_and_development_of_new_antibiotics\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">De-linkage and development of new antibiotics</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#See_also\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=De-linkage&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>De-linkage was first promoted by <a href=\"/wiki/Civil_society\" title=\"Civil society\">civil society</a> organizations as a better way of financing <a href=\"/wiki/Research_and_development\" title=\"Research and development\">research and development</a> than the patent-based system. This was opposed by the industry as it was seen as an attack on the patent system on which the current business model depended. It was also questioned because it involved governments deciding how R&amp;D should be rewarded instead of the <a href=\"/wiki/Free_market\" title=\"Free market\">free market</a>.<sup id=\"cite_ref-ch-20150514_1-3\" class=\"reference\"><a href=\"#cite_note-ch-20150514-1\">&#91;1&#93;</a></sup>. An early effort to implement delinkage of R&amp;D incentives from drug prices was the Medical Innovation Prize Fund legislation first introduced in the House of Representatives by Bernie Sanders in 2005, and subsequently revised and reintroduced several times.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (August 2018)\">citation needed</span></a></i>&#93;</sup> Several national governments support measures to move toward delinkage.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (August 2018)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"De-linkage_and_development_of_new_antibiotics\">De-linkage and development of new antibiotics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=De-linkage&amp;action=edit&amp;section=2\" title=\"Edit section: De-linkage and development of new antibiotics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:312px;\"><a href=\"/wiki/File:Antibiotic_sensitvity_and_resistance.JPG\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/20/Antibiotic_sensitvity_and_resistance.JPG/310px-Antibiotic_sensitvity_and_resistance.JPG\" width=\"310\" height=\"161\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/20/Antibiotic_sensitvity_and_resistance.JPG/465px-Antibiotic_sensitvity_and_resistance.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/20/Antibiotic_sensitvity_and_resistance.JPG/620px-Antibiotic_sensitvity_and_resistance.JPG 2x\" data-file-width=\"2456\" data-file-height=\"1273\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Antibiotic_sensitvity_and_resistance.JPG\" class=\"internal\" title=\"Enlarge\"></a></div><a href=\"/wiki/Antimicrobial_resistance\" title=\"Antimicrobial resistance\">Antibiotic resistance tests</a></div></div></div>\n<p>Until resistance has emerged against a previous generation of antibiotic, commercial return for any given new drug is uncertain.<sup id=\"cite_ref-amr-201505_2-1\" class=\"reference\"><a href=\"#cite_note-amr-201505-2\">&#91;2&#93;</a></sup> Therefore, the de-linkage model may be preferable in the context of developing new antibiotics and the fight against resistance where new <a href=\"/wiki/Antibiotics\" class=\"mw-redirect\" title=\"Antibiotics\">antibiotics</a> initially are unlikely to sell in large quantities because they should be reserved for use only when all other options have been exhausted. De-linkage also removes the incentive for the industry to boost sales that may encourage overuse that accelerate the development of <a href=\"/wiki/Antimicrobial_resistance\" title=\"Antimicrobial resistance\">antibiotic resistance</a>.<sup id=\"cite_ref-ch-20150514_1-4\" class=\"reference\"><a href=\"#cite_note-ch-20150514-1\">&#91;1&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=De-linkage&amp;action=edit&amp;section=3\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Decoupling_(utility_regulation)\" title=\"Decoupling (utility regulation)\">Decoupling (utility regulation)</a></li>\n<li><a href=\"/wiki/Attention_economy\" title=\"Attention economy\">Attention economy</a>, <a href=\"/w/index.php?title=Time_on_site&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Time on site (page does not exist)\">time on site</a> and the link between profit and customer attention<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=De-linkage&amp;action=edit&amp;section=4\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-ch-20150514-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ch-20150514_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ch-20150514_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ch-20150514_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-ch-20150514_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-ch-20150514_1-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\">Charles Clift. \"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.chathamhouse.org/expert/comment/17659\">De-linkage: A Way Forward for Antimicrobial Drugs</a>\", chathamhouse.org, 14 May 2015. Retrieved 7 May 2016.</span>\n</li>\n<li id=\"cite_note-amr-201505-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-amr-201505_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-amr-201505_2-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Jim O\u2019Neill. \"<a rel=\"nofollow\" class=\"external text\" href=\"http://amr-review.org/sites/default/files/SECURING%20NEW%20DRUGS%20FOR%20FUTURE%20GENERATIONS%20FINAL%20WEB_0.pdf\">Securing New Drugs for Future Generations: The Pipeline of Antibiotics \u2014 The Review on Antimicrobial Resistance</a>\" p2, amr-review.org, May 2015. Retrieved 7 May 2016.</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\">\"<a rel=\"nofollow\" class=\"external text\" href=\"https://www.youtube.com/watch?v=jlPF9_1VIso#t=23m00s\">Sam Harris #71 - What is Technology Doing to Us? (with Tristan Harris)</a>\", Design Ethicist Tristan Harris of <a href=\"/wiki/Time_Well_Spent\" title=\"Time Well Spent\">Time Well Spent</a> in Sam Harris's podcast <i><a href=\"/wiki/Sam_Harris#The_Waking_Up_podcast\" title=\"Sam Harris\">Waking Up</a></i>, 19 April 2017. Retrieved 29 October 2017.</span>\n</li>\n</ol></div>\n\n<!-- \nNewPP limit report\nParsed by mw2220\nCached time: 20180922101244\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.084 seconds\nReal time usage: 0.121 seconds\nPreprocessor visited node count: 347/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 3720/2097152 bytes\nTemplate argument size: 956/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 2633/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.027/10.000 seconds\nLua memory usage: 1.11 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   76.843      1 -total\n 99.87%   76.745      2 Template:Cn\n 74.30%   57.098      2 Template:Fix\n 41.82%   32.134      4 Template:Category_handler\n 21.80%   16.750      2 Template:Delink\n  4.12%    3.162      2 Template:Fix/category\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:50462832-0!canonical and timestamp 20180922101244 and revision id 854102655\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_August_2018"},{"sortkey":"","*":"Pharmaceutical_industry"},{"sortkey":"","*":"Research_and_development"},{"sortkey":"","*":"Patent_law"},{"sortkey":"","*":"Monopoly_(economics)"},{"sortkey":"","*":"Antibiotic_resistance"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from August 2018"},{"ns":0,"exists":"","*":"Antibiotics"},{"ns":0,"exists":"","*":"Antimicrobial resistance"},{"ns":0,"exists":"","*":"Attention economy"},{"ns":0,"exists":"","*":"Business model"},{"ns":0,"exists":"","*":"Civil society"},{"ns":0,"exists":"","*":"Decoupling (utility regulation)"},{"ns":0,"exists":"","*":"Free market"},{"ns":0,"exists":"","*":"Monopoly"},{"ns":0,"exists":"","*":"Patent"},{"ns":0,"exists":"","*":"Pharmaceutical drug"},{"ns":0,"exists":"","*":"Pharmaceutical industry"},{"ns":0,"exists":"","*":"Research and development"},{"ns":0,"exists":"","*":"Sam Harris"},{"ns":0,"exists":"","*":"Time Well Spent"},{"ns":0,"*":"Time on site"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"}],"templates":[{"ns":10,"exists":"","*":"Template:Cn"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"}],"images":["Antibiotic_sensitvity_and_resistance.JPG"],"externallinks":["https://www.chathamhouse.org/expert/comment/17659","http://amr-review.org/sites/default/files/SECURING%20NEW%20DRUGS%20FOR%20FUTURE%20GENERATIONS%20FINAL%20WEB_0.pdf","https://www.youtube.com/watch?v=jlPF9_1VIso#t=23m00s"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"De-linkage","byteoffset":911,"anchor":"History"},{"toclevel":1,"level":"2","line":"De-linkage and development of new antibiotics","number":"2","index":"2","fromtitle":"De-linkage","byteoffset":1731,"anchor":"De-linkage_and_development_of_new_antibiotics"},{"toclevel":1,"level":"2","line":"See also","number":"3","index":"3","fromtitle":"De-linkage","byteoffset":2571,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"4","fromtitle":"De-linkage","byteoffset":3029,"anchor":"References"}],"parsewarnings":[],"displaytitle":"De-linkage","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q25245631"}]}}